Virus vs. superbug: first patient sought for groundbreaking lung infection trial
NCT ID NCT07429162
Summary
This is an early safety study for a single patient with a severe, antibiotic-resistant lung infection. It will test a new therapy that uses special viruses (called phages) designed to attack the bacteria, given alongside standard antibiotics. The goal is to see if this combination can reduce the amount of bacteria in the lungs and improve the patient's breathing and health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.